Pfizer Inc.

Last Updated: June 7, 2026 at 10:18 a.m. ETFirst Published: June 6, 2026 at 2:53 p.m. ET One of the…

Approval expands HYMPAVZI use to now include people with hemophilia A or B ages 12 years and older…

The highly anticipated SpaceX mega-IPO is part of a space frenzy that is moving beyond satellite connectivity, launch…

With a market cap of $149.2 billion, Pfizer Inc. (PFE) is a global biopharmaceutical company that discovers, develops, manufactures,…

Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press |…

Thomas Fuller | Nurphoto | Getty Images Pfizer on Monday said it will seek regulatory approval for a…

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark,…

Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…

Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in…

President Donald Trump launched a new website to help Americans directly buy select medicines at a discount, seeking…

Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it…

Boxes of the drug trulicity, made by Eli Lilly and Company, sit on a counter at a pharmacy…

U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need